| Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study AR Kodahl, MB Lyng, H Binder, S Cold, K Gravgaard, AS Knoop, ... Molecular oncology 8 (5), 874-883, 2014 | 213 | 2014 |
| The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer KH Gravgaard, MB Lyng, AV Laenkholm, R Søkilde, BS Nielsen, T Litman, ... Breast cancer research and treatment 134, 207-217, 2012 | 121 | 2012 |
| Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study MB Lyng, AV Lænkholm, R Søkilde, KH Gravgaard, T Litman, HJ Ditzel PloS one 7 (5), e36170, 2012 | 78 | 2012 |
| Gene expression signatures that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study MB Lyng, AV Lænkholm, Q Tan, W Vach, KH Gravgaard, A Knoop, ... PLoS One 8 (1), e54078, 2013 | 17 | 2013 |
| Gene expression profile that predict outcome of tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study MB Lyng, AV Lænkholm, Q Tan, W Vach, KH Gravgaard, A Knoop, ... | 1 | 2012 |
| MikroRNA er assioceret med tumorprogression og endokrin resistens i brystkræfttumorer KH Gravgaard | | 2014 |
| Metastasis Development and Endocrine Resistance in Breast Cancer: PhD Thesis KH Gravgaard Institute of Molecular Medicine, University of Southern Denmark, 2014 | | 2014 |
| Metastasis Development and Endocrine Resistance in Breast Cancer KH Gravgaard Syddansk Universitet, 2014 | | 2014 |
| Abstract P4-09-04: Gene expression profile that predict outcome of Tamoxifen-treated estrogen receptor-positive, high-risk, primary breast cancer patients: a DBCG study. MB Lyng, AV Lænkholm, Q Tan, W Vach, KH Gravgaard, A Knoop, ... Cancer Research 72 (24_Supplement), P4-09-04-P4-09-04, 2012 | | 2012 |
| The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer KH Gravgaard, MB Lyng, AV Laenkholm, R Søkilde, BS Nielsen, T Litman, ... Breast Cancer Research 13, 1-9, 2011 | | 2011 |
| Potential underlying EMT mechanisms identified by global miRNA expression profiling of Tamoxifen-treated breast cancer patients MB Lyng, AV Lænkholm, R Søkilde, KH Gravgaard, T Litman, H Ditzel | | 2011 |
| The miRNA-200 family and miRNA-9 exhibit differential expression in primary vs. corresponding metastatic tissue in breast cancer. KH Gravgaard | | 2011 |
| Global miRNA expression profiling of high-risk estrogen receptor-positive breast cancer patients treated with Tamoxifen MB Lyng, AV Lænkholm, R Søkilde, KH Gravgaard, T Litman, H Ditzel | | 2011 |
